Clinical Trial Update: The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acids for non-alcoholic fatty liver disease has completed. Sponsor: University of Edinburgh.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Edinburgh | Conditions: Non Alcoholic Fatty Liver Disease | Phase 3 | Status: COMPLETED